Device and method for enhanced visualization of the small intestine

Information

  • Patent Grant
  • 11944277
  • Patent Number
    11,944,277
  • Date Filed
    Monday, September 20, 2021
    2 years ago
  • Date Issued
    Tuesday, April 2, 2024
    a month ago
Abstract
A device for distending a body lumen for enhanced visualization with a capsule endoscope that includes a camera lens includes an attachment element configured to attach to the capsule endoscope and a plurality of struts extending from the attachment element and meeting at an apex. The plurality of struts are configured to extend both axially and radially away from the camera lens so as to form a frame therearound.
Description
INCORPORATION BY REFERENCE

All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.


BACKGROUND

Endoscopy, the study or examination of the inside of the body, is a common procedure performed by gastroenterologists inside of the gastrointestinal (GI) tract. It is typically accomplished with long, slender endoscopes, either rigid or flexible.


For typical endoscopy, visualization of the GI tract is significantly enhanced by insufflation, i.e., the release of pressurized gas (air or CO2). Because collapsed tissue inhibits visualization, insufflation is used to expand or distend the GI tract so that it can be fully visualized. Without such inflation, endoscopy moves through only a portion of an often-flattened lumen, failing to image significant parts of the lumen. As a result, incomplete evaluation of the bowel is common when insufflation is not used. Luminal distention is therefore often critical for endoscopy for better visualization, detection, and the efficacy of the entire examination. FIGS. 1A-1E shows the advantages of insufflation distention during a typical endoscopy procedure. FIG. 1A shows the intestine in its deflated state with no markers visible. FIG. 1B shows that with just 50 mL of insufflation, 4 of the 9 markes become vissible. FIG. 1C shows insufflation at 200 mL. FIG. 1D shows insufflation at 450 mL. FIG. 1E shows the intestine fully inflated at 1500 mL.


However, traditional endoscopy is invasive, usually requires anesthesia, and can be very difficult to move through the small intestine. Recently, there has been commercial success for a distinctly new class of devices known as capsule endoscopes (CE) (including pill cameras, pillcams, wireless capsule endoscopes, or video capsule endoscopes (VCE)). Capsule endoscopies have been revolutionary for gastroenterology, enabling diagnostic procedures that are non-invasive, do not require anesthesia, and provide visualization of anatomies that were previously poorly interrogated, including the small intestine. With capsule endoscopy, manufacturers have gone to great lengths to improve visualization, adding ever-more cameras, side-view cameras, rotating cameras, cameras with a widening field of view, or finer resolution, an increased quantity of more powerful LEDs, faster data transfer rates, and radically higher frame rates. However, none of these improvements are meaningful or helpful if the lumen is flattened and/or covers the lens.


For capsule endoscopy, luminal expansion techniques are currently not available. As such, the procedure's visualization, and thus its entire diagnostic yield and efficacy, is significantly limited. FIGS. 2A-2D show exemplary instances in which the field of view with a capsule endoscope can be obscured. FIG. 2A, for example, shows the lumen 220 collapsed around the capsule endoscope 222. FIG. 2B shows scope 222 oriented towards a fold in the wall of the lumen 200. FIG. 2C shows localized immersive mucosal contact of the lumen 220 with the scope 222. Finally, FIG. 2D shows deep folds in the lumen 200, which can hinder visualization with the scope 222. These exemplary scenarios can result in occlusion of the lens, a view of only the closed tissue, and/or an impartial view caused by blood, debris, or tissue interfering with the lens. As a result, typical capsule endoscope diagnostic efficacy rates are sub-par, estimated at only around 50%. Despite patient experience advantages relative to traditional endoscopic devices, these suboptimal rates have prevented the devices from reaching their potential.


Studies have been performed with capsule endoscopes that release gas into the gastrointestinal tract for insufflation, and the results show radically improved visualization. Gas release in such studies was accomplished, for example, through the release of pressurized air or as the by-product of a chemical reaction. However, storing and methodically releasing pressurized air aboard a capsule in the gastrointestinal tract is problematic. Excessive localized gas release can cause patient discomfort. Chemical reactions struggle with heat, biocompatibility, foaming and bubbles, longevity, and adequate volume.


Capsule endoscopes including built-in radial extensions have been proposed as a means of making the device more lumen-centric to improve imaging, but these structures do not serve to adequately tent small intestine tissue, as the small intestine tissue is very thin, soft, and compliant and tends to fold over onto the lens of the scope.


A device for use with a capsule endoscope that addresses some or all of these problems is thus desired.


SUMMARY OF THE DISCLOSURE

In general, in one embodiment, a device for distending a body lumen for enhanced visualization with a capsule endoscope that includes a camera lens includes an attachment element configured to attach to the capsule endoscope and a plurality of struts extending from the attachment element and meeting at an apex. The plurality of struts are configured to extend both axially and radially away from the camera lens so as to form a frame therearound with the apex positioned a set axial distance away from the camera lens.


This and other embodiments can include one or more of the following features. The attachment element can be an annular ring. The attachment element can be configured to attach to the capsule endoscope through friction fit, adhesive, or clamping. The frame can include a shoulder that is positioned a maximum radial distance away from the capsule scope. The shoulder can be axially offset away from the camera lens. A distance between the shoulder and the apex can be between 10 mm and 30 mm. A diameter of the frame at the shoulder can be between 20 mm and 40 mm. The frame can include a tapered tip. An angle of the taper can be between 30° and 60°. The set axial distance can be between 25 mm and 45 mm. The struts of the plurality of struts can be separated by 30° to 120°. There can be between 4 and 6 struts in the plurality of struts. Each of the plurality of struts can be self-expandable. Each of the plurality of struts can be formed of a shape memory material. The frame can include a biodegradable portion.


In general, in one embodiment, a device for visualization of a body lumen includes a capsule endoscope with a camera lens and a plurality of struts extending from the capsule endoscope and meeting at an apex. The plurality of struts extend both axially and radially away from the camera lens so as to form a frame therearound with the apex positioned a set axial distance away from the camera lens.


This and other embodiments can include one or more of the following features. The frame can include a shoulder that is positioned a maximum radial distance away from the capsule endoscope. The shoulder can be axially offset away from the camera lens. A distance between the shoulder and the apex can be between 10 mm and 30 mm. A diameter of the frame at the shoulder can be between 20 mm and 40 mm. The frame can include a tapered tip. An angle of the taper can be between 30° and 60°. The set axial distance can be between 25 mm and 45 mm. The struts of the plurality of struts can be separated by 30° to 120°. There can be between 4 and 6 struts in the plurality of struts. Each of the plurality of struts can be self-expandable. Each of the plurality of struts can be formed of a shape memory material. The frame can include a biodegradable portion.


In general, in one embodiment, a method of enhancing visualization of a body lumen includes: (1) positioning a device including a capsule endoscope and a plurality of struts attached thereto into a body lumen; (2) expanding the plurality of struts of the device within the body lumen such that the plurality of struts extend both radially and axially away from a camera lens of the capsule endoscope and meet at an apex that is positioned a set axial distance away from the camera lens; and (3) imaging with the camera lens into the body lumen.


This and other embodiments can include one or more of the following features. The plurality of struts can form a frame around the camera lens upon expansion. The frame can include a shoulder that is positioned a maximum radial distance away from the capsule endoscope. The shoulder can be axially offset away from the camera lens. A distance between the shoulder and the apex can be between 10 mm and 30 mm. A diameter of the frame at the shoulder can be between 20 mm and 40 mm. The plurality of struts can form a frame around the camera lens upon expansion. The frame can include a tapered tip. An angle of the taper can be between 30° and 60°. The set axial distance can be between 25 mm and 45 mm. The struts of the plurality of struts can be separated by 30° to 120° upon expansion. There can be between 4 and 6 struts in the plurality of struts. Expanding the plurality of struts can include self-expanding the plurality of struts. Each of the plurality of struts can be formed of a shape memory material. The plurality of struts can form a frame around the camera lens upon expansion. The method can further include dissolving at least a portion of the frame to allow passage of the device from the body.


In general, in one embodiment, a device for distending a body lumen for enhanced visualization with a capsule endoscope that includes a camera lens includes an attachment element configured to attach to the capsule endoscope and a plurality of struts fixed to the attachment element. The plurality of struts are configured to self-expand from a constrained configuration to an expanded configuration in which the plurality of struts extend both axially and radially away from the camera lens so as to form a frame therearound.


This and other embodiments can include one or more of the following features. The struts can be configured to self-expand based upon a trigger within the body lumen. The attachment element can be an annular ring. The attachment element can be configured to attach to the capsule endoscope through friction fit, adhesive, or clamping. The frame can include a tapered tip. An angle of the taper can be between 30° and 60°. The struts of the plurality of struts can be separated by 30° to 120° in the expanded configuration. There can be between 4 and 6 struts in the plurality of struts. Each of the plurality of struts can be formed of a shape memory material. The frame can include a biodegradable portion.


In general, in one embodiment, a device for visualization of a body lumen includes a capsule endoscope with a camera lens and a plurality of struts attached to the capsule endoscope. The plurality of struts are configured to self-expand from a constrained configuration to an expanded configuration in which the plurality of struts extend both axially and radially away from the camera lens so as to form a frame therearound.


This and other embodiments can include one or more of the following features. The device can further include a covering around the struts configured to hold the plurality of struts in the constrained configuration. The covering can be configured to dissolve in the body lumen. The struts can be configured to self-expand based upon a trigger within the body lumen. The frame can include a tapered tip. An angle of the taper can be between 30° and 60°. The struts of the plurality of struts can be separated by 30° to 120° in the expanded configuration. There can be between 4 and 6 struts in the plurality of struts. Each of the plurality of struts can be formed of a shape memory material. The frame can include a biodegradable portion.


In general, in one embodiment, a method of enhancing visualization of a body lumen includes: (1) positioning a device including a capsule endoscope and a plurality of struts attached thereto into a body lumen; (2) self-expanding the plurality of struts of the device within the body lumen from a constrained configuration to an expanded configuration in which the plurality of struts extend both radially and axially away from a camera lens of the capsule endoscope; and (3) imaging with the camera lens through the frame into the body lumen.


This and other embodiments can include one or more of the following features. The frame can include a tapered tip. An angle of the taper can be between 30° and 60°. The struts of the plurality of struts can be separated by 30° to 120° in the expanded configuration. There can be between 4 and 6 struts in the plurality of struts. Each of the plurality of struts can be formed of a shape memory material. The plurality of struts can form a frame around the camera lens in the expanded configuration. The method can further include dissolving at least a portion of the frame to allow passage of the device from the body.


In general, in one embodiment, a device for distending a body lumen for enhanced visualization with a capsule endoscope that includes a camera lens includes an attachment element configured to attach to the capsule endoscope and a plurality of struts fixed to the attachment element. The plurality of struts are configured to extend both axially and radially away from the camera lens so as to form a frame therearound. The frame further includes one or more biodegradable portions.


This and other embodiments can include one or more of the following features. The one or more biodegradable portions can include a node between struts. The plurality of struts can include rounded ends upon biodegradation of the node. The one or more biodegradable portions can include a node within a strut. The frame can include a tapered tip. An angle of the taper can be between 30° and 60°. The struts of the plurality of struts can be separated by 30° to 120°. There can be between 4 and 6 struts in the plurality of struts. Each of the plurality of struts can be self-expandable. Each of the plurality of struts can be formed of a shape memory material. The attachment element can be an annular ring. The attachment element can be configured to attach to the capsule endoscope through friction fit, adhesive, or clamping.


In general, in one embodiment, a device for visualization of a body lumen includes a capsule endoscope with a camera lens and a plurality of struts attached to the capsule endoscope. The plurality of struts are configured to extend both axially and radially away from the camera lens so as to form a frame therearound. The frame further includes one or more biodegradable portions.


This and other embodiments can include one or more of the following features. The one or more biodegradable portions can include a node between struts. Each of the plurality of struts can include rounded ends upon biodegradation of the node. The one or more biodegradable portions can include a node within a strut. The frame can include a tapered tip. An angle of the taper can be between 30° and 60°. The struts of the plurality of struts can be separated by 30° to 120°. There can be between 4 and 6 struts in the plurality of struts. Each of the plurality of struts can be self-expandable. Each of the plurality of struts can be formed of a shape memory material.


In general, in one embodiment, a method of enhancing visualization of a body lumen includes (1) positioning a device including a capsule endoscope and a plurality of struts attached thereto into a body lumen; (2) expanding the plurality of struts of the device within the body lumen such that the plurality of struts extend both radially and axially away from a camera lens of the capsule endoscope to form a frame therearound; (3) imaging with the camera lens through the frame into the body lumen; and (4) dissolving at least a portion of the frame to allow passage of the device from the body lumen.


This and other embodiments can include one or more of the following features. The frame can include a tapered tip. An angle of the taper can be between 30° and 60°. The struts of the plurality of struts can be separated by 30° to 120° upon expansion. There can be between 4 and 6 struts in the plurality of struts. Each of the plurality of struts can be formed of a shape memory material. The method can further include dissolving at least a portion of the frame to allow passage of the device from the body. The portion of the frame can include a node between struts. The plurality of struts can include rounded ends upon biodegradation of the node. The portion of the frame can include a node within a strut.





BRIEF DESCRIPTION OF THE DRAWINGS

The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:



FIGS. 1A-1E show the intestine at various stages of insufflation.



FIGS. 2A-2D are schematics showing exemplary instances in which the field of view with a capsule endoscope can be obscured.



FIG. 3 shows a capsule endoscope with an exemplary luminal expansion device projecting from the proximal and distal ends.



FIG. 4 shows a capsule endoscope with an exemplary luminal expansion device projecting from the distal end.



FIGS. 5A-5B show dimensions of an exemplary luminal expansion device.



FIG. 6 shows an exemplary rounded luminal expansion device.



FIG. 7 shows a luminal expansion device including an inflatable element.



FIG. 8 shows a spiral luminal expansion device.



FIG. 9 shows a luminal expansion device including an injection molded dome with struts.



FIG. 10 shows an injection molded luminal expansion device with a plurality of apertures therein.



FIG. 11 shows an injection molded luminal expansion device with domes on the proximal and distal ends.



FIG. 12 shows a luminal expansion device in a rounded dome shape with a low curvature.



FIG. 13 shows a luminal expansion device in a rounded dome shape with a medium curvature.



FIG. 14 shows a luminal expansion device in a rounded dome shape with a high curvature.



FIG. 15 shows a luminal expansion device with struts spiraled away from the attachment mechanism.



FIG. 16 shows another luminal expansion device with struts spiraled away from the attachment mechanism.



FIG. 17 shows a luminal expansion device including a cylindrical cage with a tapered tip.



FIG. 18 shows a spherical luminal expansion device.



FIG. 19 shows a disk shaped luminal expansion device.



FIG. 20 shows a spiral luminal expansion device.



FIG. 21 shows a luminal expansion device attached to the end of a catheter endoscope.



FIGS. 22A-C show an exemplary luminal expansion device for a side-viewing capsule endoscope.



FIG. 23A shows use of a tube to collapse a luminal expansion device.



FIG. 23B shows a capsule over a collapsed luminal expansion device.



FIG. 24 shows a loop of a luminal expansion device.



FIG. 25A shows a luminal expansion device with biodegradable nodes.



FIG. 25B shows a separated portion of the luminal expansion device of FIG. 25A.



FIGS. 26A-26B shows struts that have been dissolved from a luminal expansion device.



FIG. 27 shows exemplary decay rates of different nodes of a luminal expansion device.



FIG. 28 shows use of a luminal expansion device inside the gastrointestinal tract.



FIG. 29 shows a luminal expansion device with a tug used inside of the gastrointestinal tract.



FIG. 30A shows an image gathered from a capsule endoscope inside a lumen when a luminal expansion device is used.



FIG. 30B shows an image gathered from a capsule endoscope inside a lumen when a luminal expansion device is not used.





DETAILED DESCRIPTION

Described herein are devices for use with a capsule endoscope (CE) (a pill camera, pillcam, wireless capsule endoscope, or video capsule endoscope (VCE)) that significantly aid in more complete luminal visualization during capsule endoscopy. The devices create local distension of gastrointestinal luminal tissue away from the camera, improving diagnostic yield.


An exemplary luminal expansion device 300 is shown in FIG. 3. The device 300 includes a central attachment mechanism 303 configured to attach to the capsule endoscope 305. For example, the attachment mechanism 303 can be an annular ring. Further, the attachment mechanism 303 can be configured to attach by friction fit, adhesive, clamp, or other attachment mechanism to or around the capsule endoscope 305. The attachment mechanism 303 can be positioned, for example, around the central portion and/or end of the capsule endoscope 305 while still maintaining a clear lens.


A plurality of radiating struts 301 extend from the attachment mechanism 303. The struts 301 emerge from the attachment mechanism 303 (and thus the capsule endoscope 305), extending both axially and radially outward from the camera lens. In other words, the struts 301 are positioned away from the end of the capsule endoscope 305 along the axis 399 (or parallel to the axis 399). The struts 301 also extend radially away from the central axis 399. The struts 301 can each form a shoulder 336 that is radially offset from the camera lens (i.e., to hold tissue away from the sides of the lens of the capsule endoscope 305). The shoulder 336 can be positioned at the maximum radial distance away from the capsule endoscope 305. Further, the shoulder 336 can be axially offset away from the body of the capsule endoscope 305. Further, the struts 301 can meet or cross at an apex 333, i.e., at a point positioned a maximum axial distance away from the lens of the capsule endoscope 305. In one embodiment, and as shown in FIG. 3, the struts 301 can form a loop made of two continuous struts. The struts 301 can form a frame (e.g., a cage, space frame, wire frame, stent cage, or tenting structure). The frame can be, for example, conical, tapered, or wedge-shaped with the apex 333 forming the tip and the struts widening out to the shoulders 336 before extending back, and then in towards the capsule endoscope 305.


In use, the struts 301 can be configured to distend tissue (e.g., within the small intestine) such that luminal folds are unfolded, enabling more complete visualization. The apex 333 can act as the leading edge while the wedge or conical shape of the tip can open tissue up as the device 300 moves through, maintaining an open field of view for the camera of the capsule endoscope 305. The shoulders 336 can help maintain a wide field of view in front of the lens. Moreover, the gaps between the struts 301 can create apertures that allow direct, unobscured tissue viewing. The primarily open structure of the device 300 can further enable the thru-passage of matter, such as chyme, during use.


As shown in FIG. 3, in some embodiments, struts 301 can extend from both the proximal end and the distal end (e.g., so as to allow for imaging through lenses on both the proximal and distal ends). In other embodiments, as shown in FIG. 4, the device 400 can include struts 401 that extend only from a single end of the capsule endoscope 405.


Referring to FIGS. 5A-5B, the expansion device 500 can have struts 501 with configurations and dimensions that enable efficient and effective expansion of the lumen. For example, the length L from the apex 533 to the opposite end of the capsule endoscope 505 (i.e., the length of the device 500 plus the endoscope 505 when the device 500 is positioned on the endoscope 505) can be 35 mm-80 mm, such as 50-70 mm. Further, the length L2 from the end of the scope 505 to the apex 533 (i.e., the axial length that the apex 533 extends away from the scope 505) can 10 mm-50 mm, such as 25-45 mm. The length L3 (e.g., the length of the taper from the shoulder 536 to the apex 533) can be 5 mm-40 mm, such as 10 mm-30 mm. The length L4, i.e., the length of the capsule endoscope 505, is typically 24 mm-31 mm, and the diameter D1, i.e., the diameter of the capsule endoscope 505, is typically 9-13 mm, such as approximately 11 mm. The diameter D2 of the device 500 (i.e., from shoulder 536 to shoulder 536) can be 15-65 mm, such as 20-40 mm. Further, the angle of the taper A1 (i.e., the angle that a strut 501 makes with the longitudinal axis of the device 555) can be 30° to 60°, such as 45°. Finally, the angle A2 between neighboring struts 501 can be, for example, 30 to 120 degrees.


The number of struts in each expansion device, and their contacting areas, can vary. For example, the device can include between 3 and 12 struts, such as between 4 and 6 struts, on the distal side and/or the proximal side of the capsule endoscope.


Further, the struts can be spring-like, resilient, or deformable, such that they create an expansive outward force, but are also still flexible enough such that they can be compressed by a sphincter, orifice, or stricture. In some embodiments, for example, the struts can be made of Nitinol wire and can have a diameter, for example, of 0.010 inches to 0.020 inches, such as 0.013 inches or 0.016 inches. In another embodiments, the struts can be made, for example, of a collagen or PEEK suture material and can have a diameter, for example, of 0.020 inches to 0.060 inches, such as 0.030 inches.


In some embodiments, as with devices 300, 400, 500, the shoulder area (335, 436, 536) can extend substantially parallel to the longitudinal axis of the device, thereby creating a non-rounded or flattened portion of each strut. In other embodiments, as shown in FIG. 6, the struts 601 of the device 600 can be rounded through the shoulder 636. Further, in some embodiments, the struts 601 can be rounded through the apex 633. For example, the device 600 can take on a rounded dome shape. Similar rounded dome-shaped devices are shown in FIGS. 12-14. In FIG. 12, for example, there are six struts 1201 that extended in a rounded dome shape and meet at apex 1233. FIG. 13 similarly has four struts 1301 that extend through rounded shoulders and meet at apex 1333. The struts 1201, 1301 of FIGS. 12 and 13 have a fairly low curvature and result in a frame or cage with a fairly low diameter (e.g., with a diameter that is only 10-30% greater than the diameter of the capsule itself). In contrast, FIG. 14 shows a device 1400 with struts 1401 that have larger curvature and result in a frame or cage with a fairly high diameter (e.g., with a diameter that is 50%-150% greater than the diameter of the capsule itself).


Referring to FIG. 15, in some embodiments, the struts 1501 can be spiraled away from the attachment mechanism 1503. That is, while the struts 1501 meet in an apex 1533, they do not extend in a single plane that is extends through the central longitudinal axis (as in devices 300, 400, 500, 600). Rather, each strut 1501 wraps circumferentially around the longitudinal axis of the capsule endoscope 1505 (while still extending radially outwards and axially away from the attachment mechanism 1503). FIG. 16 shows a similar device 1600 with struts 1601 that both spiral and extend through an apex 1633.


Referring to FIGS. 22A-22C, in some embodiments, the struts 2201 can be positioned such that the apex 2233 is near or adjacent to the proximal and/or distal end of the capsule endoscope 2205 while the struts are held or positioned a set radial distance away from the capsule endoscope 2205 along substantially the entire length of the scope 2205. In this configuration, the shoulder 2236 is positioned radially away from, and axially aligned with the capsule endoscope 2205. In such an example, the attachment mechanism between the capsule endoscope 2205 and the struts 2201 can be, for example, at the apex 2233. The device 2200 can be advantageous for a capsule endoscope that has side-viewing cameras (such side-viewing cameras can utilize multiple cameras configured in an array, typically each at or near the capsule endoscopes's axial center).


Further, as shown in FIG. 8, in some embodiments, the expansion device 800 can include a coiled strut 801 that coils or spirals around the attachment mechanism 803. The coiled strut 801 can be coiled so as to extend away from the attachment mechanism 803. Further, in some embodiments, as shown in FIG. 20, the coiled strut 2001 can taper down at the proximal and/or distal end to aid in navigating through the lumen.


Referring to FIGS. 17-19, in some embodiments, the expansion device can include a cage that is made of a plurality of strut elements that interconnect at various locations. For example, device 1700 includes a plurality of struts 1701 that meet at a circular ring 1717 in a cylindrical shape and then continue on to apex 1733. FIG. 1800 shows a device 1800 with struts 1801 that cross-over mid-way down the frame to form a substantially spherical shape. Finally, FIG. 19 shows a device 1900 with struts 1901 that form a disk-shaped cage.


In some embodiments, the expansion device can be injection molded, such as an injection-molded polymer (e.g., PEEK, polypropylene, polyethylene, or a high durometer elastomer such as silicone or urethane). For example, FIG. 9 shows a device 900 that includes an injection molded dome that is formed of struts that meet at an apex 933. FIG. 11 shows a similar injection-molded device 1100 with domes on both the proximal and distal ends that are made of struts 1101a,b that meet at an apex 1133a,b. Further, FIG. 10 shows an injection molded device 1000 having a series of interconnected struts 1001 that form open cells around the perimeter thereof.


In some embodiments, the device can include a central strut with radiating umbrella-like tip elements.


In some embodiments, the expansion device can have a geometry that enables collapsing for oral entry, as seen in FIG. 23A-B. For example, the device 2300 (which can be any of the devices described herein) can be folded, bent, rolled-up, spiral wound, or compressed to the collapsed configuration. Further, as shown in FIG. 23A, in some embodiments, a tube or constricting sheath 2323 can be used to collapse the frame. Moreover, as shown in FIG. 23B, a covering (e.g., a gel-cap covering) 2332 can be used to hold the device 2300 in the collapsed configuration. In some embodiments, the covering 2332 can be dissolved in the body, thereby allowing the device to expand into a larger configuration (e.g., the configurations otherwise shown herein).


The covering 2332 can be formed, for example, of polymers used in the pharmaceutical industry that selectively dissolve in the presence of fluids found in different anatomies, including enteric coatings for the delayed release of orally administered medications (Torpac Inc, Fairfield, NJ). Other examples include cellulose acetate phthalate (C-A-P, Eastman Chemicals, Kingsport, TN), Eudragit L 100 and S 100 (Evonik Industries, Darmstadt, Germany), Acryl-ese (Colorcon, West Point, PA), and Surelease (Colorcon). In some embodiments, the material for the covering 2332 can be chosen to dissolve in the colon (e.g., Eudragit S 100) or in the small intestine (e.g., other material listed hereinabove). The polymer dissolution profiles of the chosen material can be engineered from seconds to weeks, depending on the desired imaging location. Further, the covering 2332 can be single-coated, or double, triple, quadruple, or more coatings.


In some embodiments, the expansion devices described herein can have intersections (e.g. strut joints) that are fixed, pivot, hinge, slide, or are unattached in order to aid in collapse.


Once the expansion device it is in the stomach or small intestine, the struts can be expanded. For example, the struts can self-expand due to, e.g., being made of a shape memory material, such as Nitinol.


In some embodiments, expansion can occur once the device is in the small intestine. In other embodiments, expansion can occur once the device is in the stomach or the colon.


Further, expansion can occur, for example, based upon a trigger, including the chemical environment (e.g., pH since the stomach is more acidic than the small intestine), moisture, pressure, temperature, or enzymatic activity, time, location, or visual clues (e.g., the camera can recognize villi, which only occur in the small intestine). In other embodiments, expansion can occur, for example, based upon a dissolution mechanism (such as dissolution of the covering described above) or micro-actuators that are electrically triggered (including the use of micro motors, reed switches, magnetic actuators, piezo actuators, nitinol heated by a battery, or a membrane heated by a battery to release gas, chemicals, or mechanical motion).


Referring to FIGS. 24-26B, in some embodiments, elements of the frame and/or struts can be biodegradable and/or can include biodegradable (bio-decaying or corroding) nodes. The nodes can be placed at the joints (i.e., at the junction between two struts) or can be placed within a strut. The biodegradable elements or nodes can detach, shrink, disintegrate, or dissolve before the device is expelled by the body. When dissolved, the struts and/or strut sub-elements (if the nodes are within the strut) can separate from one another to help with expulsion. Such biodegradable materials can include: Magnesium alloys, absorbable suture materials (including PGA, PLA, PLGA and collagen), PVA plastics (including Aquasol and Monosol), lactose, cellulose-acetate, and a range of bio-based plant materials, including cotton, flax, bamboo, jute, hemp, wood, coconut. In some embodiments, the biodegradable elements can be made of edible material, for example pasta derivatives.


As shown in FIG. 24, a device 2400 can include two struts 2401a,b connected together in a loop by node 2424. In some embodiments, the node 2424 can be biodegradable to allow the loop to separate into a straight segment. In other embodiments, the node 2424 can be permanent such that the loop itself can pass (e.g., the loop can be configured to biodegrade from a larger frame structure). As shown in FIG. 25, a device 2500 can include six struts 2501 and a plurality of biodegradable nodes 2524. For example, nodes 2524a, 22524b, and 2524c can all partially or fully dissolve to create an elongate piece that more easily passes, as shown in FIG. 25B. FIGS. 26A and 26B show additional struts 2601a,b and nodes 2624a,b that would be the resultant elements after nodal decay.


As shown in FIGS. 25-26B, each node can encase a joint between two struts or strut segments. Further, the nodes can be spherical or ovoid. In addition, as shown in FIG. 26B, the ends 2626a,b of each strut 2601 at the node can be spherical or otherwise atraumatic so that they do not harm the tissue upon dissolution of the nodes.


In some embodiments, the struts can be pre-shaped such that they coil or otherwise shrink into smaller shapes once they have been separated at biodegradable joints.


In some embodiments, the expansion device can have components with different dissolution rates. In one example, there can be sub-element struts that decompose slowly (e.g. over days or weeks) coupled by fusible nodes that decompose more rapidly (e.g., within 24 hours). An exemplary chart of dissolution of structures is shown in FIG. 27, where curve A signifies a faster decay time, and curve C signifies a slower decay time.


In some embodiments, the entire structure of the struts can decompose.


Dissolution of all or portions of the devices described herein can aid in passage through the body.


In some embodiments, the struts or other surfaces of the devices described herein can have surface features incorporated thereon. For example, the struts can have coatings that create either enhanced or lowered frictional values. The surface features in some embodiments can be very small external protrusions or scales to create a retarding or grabbing effect.


The expansion devices described herein can be comprised of a material that does not readily corrode. The material can be elastic or superelastic (e.g., nitinol). The material can be, for example, a hydrocarbon or a plastic, such as nylon, polycarbonate, or polyethylene, or an elastomer, including a silicone, urethane, or pebax. The struts and other structures of the devices described herein can be heat set, molded, cast, adhered, or otherwise formed.


In some embodiments, the devices described herein can be covered with one or more sheets, including clear sheets. The sheets can be treated so that they readily repel or attract wet tissue.


In some embodiments, parts of the expansion devices described herein can be infused with radio-opaque materials to aid in fluoroscopy visualization.


In some embodiments, the luminal expansion devices described herein can be symmetrical (i.e., can be created through an axis of rotation). In other embodiments, the devices can be asymmetric.


In some embodiments, the leading edge or apex of the expansion device can be tapered, bullet-nosed, conical, or rounded.


The struts of the devices described herein can have a circular, oval, square, rectangular, or other cross section.


The struts of the devices described herein can be monolithic, i.e., made of a single material. In other embodiments, the struts can be composite structures, such as be made of tubes with an outer layer (with its own properties and materials) and an inner portion (with its own properties and materials). In one embodiment, the struts can be small tubes that are inflated with a pressurized fluid or gas.


In some embodiments, referring to FIG. 7, the devices described herein can include an inflatable element 777, such as a balloon, configured hold the tissue away from the capsule. The inflatable element 777 can be used in addition to or in place of the cage and strut elements described herein.


The expansion devices described herein can attach to the housing of the capsule endoscope or to the optical hood of the capsule endoscope. In some embodiments, the expansion device can be designed as an integral part of the capsule endoscope.


Referring to FIG. 28, an expansion device 2800 as described herein can advance like other swallowed capsule endoscope devices, i.e., thru GI-tract contractions, including peristalsis. The device may not retard speed-of-passage, but instead it can enhance speed-of-passage, in effect serving to ‘super-trigger’ peristalsis, including through enhanced area, length, and contact points. The device can thus be used to image, for example, the small intestine or the colon.


Further, referring to FIG. 29, in some embodiments, a small tug element 2929 can be attached to the struts 2901 with a tensile member 2930. The small tug element 2929 can thus easily pass through the pylorus and, as it is propelled, pull the struts 2901 and attached capsule endoscope 2905 through the pylorus and into the duodenum.


Alternatively, in some embodiments, the expansion device (and capsule endoscope) can be directly placed into the stomach with an ancillary device.


The expansion devices described herein can advantageously improve the field of view when used with a capsule endoscope. FIG. 30A shows an image gathered of a small intestine with a capsule endoscope when an expansion device is used while FIG. 30B shows the image gathered without. As shown in FIG. 30B, tissue covers the lens when the expansion device is not used, thereby making it difficult to visualize within the small intestine. In contrast, when the expansion device is used (FIG. 30A), the expansion device holds the tissue away from the camera, allowing better visualization of the lumen. Because both the length and the diameter of the expansion devices described herein are larger that of the capsule endoscope itself, the devices can help keep tissue away from the capsule endoscope and create better alignment with the central axis of the lumen, thereby creating a passage that is more lumen-centric and improving image quality.


As shown in FIG. 21, in some embodiments, rather than attaching to a capsule endoscope, the expansion device 2100 can be attached to the tip of an endoscope, such as a colonoscope. The expansion device 2100 can have similar elements (e.g., struts) to any of the expansion devices described elsewhere herein.


Any of the features or elements of any of the expansion devices described herein may be combined or substituted for features or elements of any other expansion device.


Additional details pertinent to the present invention, including materials and manufacturing techniques, may be employed as within the level of those with skill in the relevant art. The same may hold true with respect to method-based aspects of the invention in terms of additional acts commonly or logically employed. Also, it is contemplated that any optional feature of the inventive variations described may be set forth and claimed independently, or in combination with any one or more of the features described herein. Likewise, reference to a singular item, includes the possibility that there are a plurality of the same items present. More specifically, as used herein and in the appended claims, the singular forms “a,” “and,” “said,” and “the” include plural referents unless the context clearly dictates otherwise. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement is intended to serve as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation. Unless defined otherwise herein, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The breadth of the present invention is not to be limited by the subject specification, but rather only by the plain meaning of the claim terms employed.


When a feature or element is herein referred to as being “on” another feature or element, it can be directly on the other feature or element or intervening features and/or elements may also be present. In contrast, when a feature or element is referred to as being “directly on” another feature or element, there are no intervening features or elements present. It will also be understood that, when a feature or element is referred to as being “connected”, “attached” or “coupled” to another feature or element, it can be directly connected, attached or coupled to the other feature or element or intervening features or elements may be present. In contrast, when a feature or element is referred to as being “directly connected”, “directly attached” or “directly coupled” to another feature or element, there are no intervening features or elements present. Although described or shown with respect to one embodiment, the features and elements so described or shown can apply to other embodiments. It will also be appreciated by those of skill in the art that references to a structure or feature that is disposed “adjacent” another feature may have portions that overlap or underlie the adjacent feature.


Terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. For example, as used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items and may be abbreviated as “/”.


Spatially relative terms, such as “under”, “below”, “lower”, “over”, “upper” and the like, may be used herein for ease of description to describe one element or feature's relationship to another element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if a device in the figures is inverted, elements described as “under” or “beneath” other elements or features would then be oriented “over” the other elements or features. Thus, the exemplary term “under” can encompass both an orientation of over and under. The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, the terms “upwardly”, “downwardly”, “vertical”, “horizontal” and the like are used herein for the purpose of explanation only unless specifically indicated otherwise.


Although the terms “first” and “second” may be used herein to describe various features/elements, these features/elements should not be limited by these terms, unless the context indicates otherwise. These terms may be used to distinguish one feature/element from another feature/element. Thus, a first feature/element discussed below can be termed a second feature/element, and similarly, a second feature/element discussed below can be termed a first feature/element without departing from the teachings of the present invention.


As used herein in the specification and claims, including as used in the examples and unless otherwise expressly specified, all numbers may be read as if prefaced by the word “about” or “approximately,” even if the term does not expressly appear. The phrase “about” or “approximately” may be used when describing magnitude and/or position to indicate that the value and/or position described is within a reasonable expected range of values and/or positions. For example, a numeric value may have a value that is +/−0.1% of the stated value (or range of values), +/−1% of the stated value (or range of values), +/−2% of the stated value (or range of values), +/−5% of the stated value (or range of values), +/−10% of the stated value (or range of values), etc. Any numerical range recited herein is intended to include all sub-ranges subsumed therein.

Claims
  • 1. A device for visualization of a body lumen, comprising: a capsule endoscope comprising a camera lens;a plurality of struts extending from the capsule endoscope radially outwardly from a longitudinal axis of the capsule endoscope and axially along the longitudinal axis of the capsule endoscope and connecting at an apex and configured to maintain a field of view around the camera lens while the device is providing visualization of the body lumen, wherein the plurality of struts extend away from the camera lens so as to form a frame therearound.
  • 2. The device of claim 1, wherein the plurality of struts is configured to distend tissue as the capsule endoscope travels through the body lumen.
  • 3. The device of claim 1, further comprising an attachment element configured to attach to the capsule endoscope, wherein the plurality of struts extend from the attachment element.
  • 4. The device of claim 1, wherein there are between 4 and 6 struts in the plurality of struts.
  • 5. The device of claim 1, wherein each of the plurality of struts is self-expandable.
  • 6. The device of claim 5, wherein each of the plurality of struts is formed of a shape memory material.
  • 7. The device of claim 1, wherein the frame includes a biodegradable portion.
  • 8. The device of claim 1, wherein the frame includes a tapered tip.
  • 9. The device of claim 8, wherein an angle of the taper is between 30° and 60° .
  • 10. A device for visualization of a body lumen, comprising: a capsule endoscope comprising a camera lens;a plurality of struts extending from the capsule endoscope and connecting at an apex and configured to maintain a field of view around the camera lens while the device is providing visualization of the body lumen, the plurality of struts forming a frame around the capsule endoscope and configured to distend tissue as the capsule endoscope travels through the body lumen.
  • 11. The device of claim 10, further comprising an attachment element configured to attach to the capsule endoscope, wherein the plurality of struts extend from the attachment element.
  • 12. The device of claim 10, wherein there are between 4 and 6 struts in the plurality of struts.
  • 13. The device of claim 10, wherein each of the plurality of struts is self-expandable.
  • 14. The device of claim 13, wherein each of the plurality of struts is formed of a shape memory material.
  • 15. The device of claim 10, wherein the frame includes a biodegradable portion.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 16/325,497, filed Feb. 14, 2019, which is a 371 of International Application No. PCT/US2017/047591, International Filing Date Aug. 18, 2017, which claims the benefit of U.S. Provisional Patent Application No. 62/376,816, filed Aug. 18, 2016 and titled “DEVICE AND METHOD FOR ENHANCED VISUALIZATION OF THE SMALL INTESTINE,” the entirety of which is incorporated by reference herein.

US Referenced Citations (375)
Number Name Date Kind
2268321 Flynn Dec 1941 A
2767705 Moore Oct 1956 A
3859986 Okada et al. Jan 1975 A
3998216 Hosono Dec 1976 A
4066071 Nagel Jan 1978 A
4141364 Schultze Feb 1979 A
4151800 Dotts et al. May 1979 A
4176662 Frazer Dec 1979 A
4425919 Alston, Jr. Jan 1984 A
4551140 Shinohara Nov 1985 A
4690131 Lyddy, Jr. et al. Sep 1987 A
4696544 Costella Sep 1987 A
4717379 Ekholmer Jan 1988 A
4794412 Casey et al. Dec 1988 A
4794912 Lia Jan 1989 A
4815450 Patel Mar 1989 A
4817613 Jaraczewski et al. Apr 1989 A
4893613 Hake Jan 1990 A
4913369 Lia et al. Apr 1990 A
4959058 Michelson Sep 1990 A
4961738 Mackin Oct 1990 A
5018436 Evangelista et al. May 1991 A
5019121 Krauter May 1991 A
5037386 Marcus et al. Aug 1991 A
5105819 Wollschlager et al. Apr 1992 A
5123421 Sinofsky Jun 1992 A
5125143 Takahashi Jun 1992 A
5174276 Crockard Dec 1992 A
5188595 Jacobi Feb 1993 A
5201908 Jones Apr 1993 A
5251611 Zehel et al. Oct 1993 A
5337733 Bauerfeind et al. Aug 1994 A
5360440 Andersen Nov 1994 A
5496292 Burnham Mar 1996 A
5531685 Hemmer et al. Jul 1996 A
5531719 Takahashi Jul 1996 A
5577992 Chiba et al. Nov 1996 A
5601588 Tonomura et al. Feb 1997 A
5603991 Kupiecki et al. Feb 1997 A
5607435 Sachdeva et al. Mar 1997 A
5624381 Kieturakis Apr 1997 A
5632734 Galel et al. May 1997 A
5662587 Grundfest et al. Sep 1997 A
5662621 Lafontaine Sep 1997 A
5746692 Bacich et al. May 1998 A
5749828 Solomon et al. May 1998 A
5759151 Sturges Jun 1998 A
5779624 Chang Jul 1998 A
5782811 Samson et al. Jul 1998 A
5823961 Fields et al. Oct 1998 A
5882347 Laan et al. Mar 1999 A
5891112 Samson Apr 1999 A
5891114 Chin et al. Apr 1999 A
5906591 Dario et al. May 1999 A
5916145 Chu et al. Jun 1999 A
5916147 Boury Jun 1999 A
5951539 Nita et al. Sep 1999 A
5976074 Moriyama Nov 1999 A
6090099 Samson et al. Jul 2000 A
6159187 Park et al. Dec 2000 A
6162171 Ng et al. Dec 2000 A
6179776 Adams et al. Jan 2001 B1
6190357 Ferrari et al. Feb 2001 B1
6217565 Cohen Apr 2001 B1
6296644 Surat et al. Oct 2001 B1
6309346 Farhadi Oct 2001 B1
6352503 Matsu et al. Mar 2002 B1
6364878 Hall Apr 2002 B1
6368315 Gillis et al. Apr 2002 B1
6468203 Belson Oct 2002 B2
6485409 Voloshin et al. Nov 2002 B1
6503225 Kirsch et al. Jan 2003 B1
6517477 Wendlandt Feb 2003 B1
6547724 Soble et al. Apr 2003 B1
6572538 Takase Jun 2003 B2
6572590 Stevens et al. Jun 2003 B1
6579277 Rabiner et al. Jun 2003 B1
6610007 Belson et al. Aug 2003 B2
6612982 Ouchi Sep 2003 B1
6616628 Hayzelden Sep 2003 B2
6620126 Unsworth et al. Sep 2003 B2
6623424 Hayakawa et al. Sep 2003 B2
6712832 Shah Mar 2004 B2
6726677 Flaherty et al. Apr 2004 B1
6730020 Peng et al. May 2004 B2
6780151 Grabover et al. Aug 2004 B2
6783491 Saadat et al. Aug 2004 B2
6790173 Saadat et al. Sep 2004 B2
6793621 Butler et al. Sep 2004 B2
6793661 Hamilton et al. Sep 2004 B2
6800056 Tartaglia et al. Oct 2004 B2
6869393 Butler Mar 2005 B2
6899673 Ogura et al. May 2005 B2
6911004 Kim et al. Jun 2005 B2
6923754 Lubock Aug 2005 B2
6960162 Saadat et al. Nov 2005 B2
6974411 Belson Dec 2005 B2
6984203 Tartaglia et al. Jan 2006 B2
7060199 Woydt et al. Jun 2006 B2
7172552 Wendlandt Feb 2007 B2
7214230 Brock et al. May 2007 B2
7288101 Deem et al. Oct 2007 B2
7291127 Eidenschink Nov 2007 B2
7365509 Park et al. Apr 2008 B2
7438712 Chouinard Oct 2008 B2
7511733 Takizawa et al. Mar 2009 B2
7537562 Takano May 2009 B2
7559916 Smith et al. Jul 2009 B2
7591782 Fujikura Sep 2009 B2
7598652 Kombluh et al. Oct 2009 B2
7695428 Machida Apr 2010 B2
7736323 Von Weymarn-Scharli Jun 2010 B2
7749196 Osborne et al. Jul 2010 B2
7837615 Le et al. Nov 2010 B2
7850725 Vardi et al. Dec 2010 B2
7901347 Sekiguchi et al. Mar 2011 B2
7909755 Itoi Mar 2011 B2
7918819 Karmarkar et al. Apr 2011 B2
7918845 Saadat et al. Apr 2011 B2
7931661 Saadat et al. Apr 2011 B2
7935047 Yoshida et al. May 2011 B2
7947000 Vargas et al. May 2011 B2
7957790 Kleen Jun 2011 B2
7970455 Zilberstein et al. Jun 2011 B2
7988621 Smith et al. Aug 2011 B2
8047236 Perry Nov 2011 B2
8075476 Vargas Dec 2011 B2
8092374 Smith et al. Jan 2012 B2
8109953 King, III et al. Feb 2012 B1
8123739 McQueen et al. Feb 2012 B2
8125755 Garcia et al. Feb 2012 B2
8192422 Zubiate et al. Jun 2012 B2
8206287 Matsuo Jun 2012 B2
8226548 Kucklick Jul 2012 B2
8241299 Hibner Aug 2012 B2
8246575 Viola Aug 2012 B2
8257257 Takizawa et al. Sep 2012 B2
8298161 Vargas Oct 2012 B2
8313014 Bettuchi Nov 2012 B2
8361090 Belson Jan 2013 B2
8366606 Watanabe et al. Feb 2013 B2
8388519 Garcia et al. Mar 2013 B2
8439825 Sekiguchi May 2013 B2
8460179 Ikeda et al. Jun 2013 B2
8485968 Weimer et al. Jul 2013 B2
8496648 Rogers Jul 2013 B2
8506479 Piskun et al. Aug 2013 B2
8517923 Belson et al. Aug 2013 B2
8545491 Abboud et al. Oct 2013 B2
8550989 Dohi et al. Oct 2013 B2
8556804 Smith et al. Oct 2013 B2
8663096 Viola Mar 2014 B2
8663196 Kassab et al. Mar 2014 B2
8708894 Smith et al. Apr 2014 B2
8721530 Ohline et al. May 2014 B2
8753312 Bowe et al. Jun 2014 B2
8777844 Sadanand Jul 2014 B1
8920369 Salahieh et al. Dec 2014 B2
8969639 Xu et al. Mar 2015 B2
9011318 Choset et al. Apr 2015 B2
9066655 Stefanchik et al. Jun 2015 B2
9114228 Zook et al. Aug 2015 B2
9125653 Kovach Sep 2015 B2
9155451 Smith et al. Oct 2015 B2
9192284 Hirsch et al. Nov 2015 B2
9192288 Okaniwa Nov 2015 B2
9211140 Lauryssen et al. Dec 2015 B2
9220398 Woodley et al. Dec 2015 B2
9226825 Starksen et al. Jan 2016 B2
9241611 Konno Jan 2016 B2
9254123 Alvarez et al. Feb 2016 B2
9295511 Smith et al. Mar 2016 B2
9358073 Piligian et al. Jun 2016 B2
9364955 Oyola et al. Jun 2016 B2
9386910 West Jul 2016 B2
9498108 Lombardi Nov 2016 B1
9498198 Hu et al. Nov 2016 B2
9505125 Zubiate et al. Nov 2016 B2
9585546 Surti et al. Mar 2017 B2
9610068 Kappel et al. Apr 2017 B2
9649473 Gregorich et al. May 2017 B2
9763562 Avitsian et al. Sep 2017 B2
9814372 Smith et al. Nov 2017 B2
9913570 Kucharski et al. Mar 2018 B2
9937324 Kim et al. Apr 2018 B2
9993142 Salman et al. Jun 2018 B2
10092291 Voegele et al. Oct 2018 B2
10307042 Lombardi Jun 2019 B2
10463495 Rogers et al. Nov 2019 B2
11122971 Tilson Sep 2021 B2
11135398 Tilson et al. Oct 2021 B2
11554248 Tilson et al. Jan 2023 B1
20010041881 Sarge et al. Nov 2001 A1
20020107478 Wendlandt Aug 2002 A1
20020161355 Wollschlager Oct 2002 A1
20030023259 Dubrul et al. Jan 2003 A1
20030035048 Shipp Feb 2003 A1
20030083546 Butler et al. May 2003 A1
20030122374 Ouchi et al. Jul 2003 A1
20030153866 Long et al. Aug 2003 A1
20030208220 Worley et al. Nov 2003 A1
20030216622 Meron Nov 2003 A1
20030216691 Jacobson Nov 2003 A1
20030225379 Schaffer et al. Dec 2003 A1
20040019252 Hirata Jan 2004 A1
20040044350 Martin et al. Mar 2004 A1
20040092960 Abrams et al. May 2004 A1
20040176664 Iddan Sep 2004 A1
20040186349 Ewers et al. Sep 2004 A1
20040186350 Brenneman et al. Sep 2004 A1
20040242958 Fujikawa et al. Dec 2004 A1
20040243227 Starksen et al. Dec 2004 A1
20040260236 Manning et al. Dec 2004 A1
20050005363 Giori et al. Jan 2005 A1
20050010237 Niazi Jan 2005 A1
20050085829 Kraemer et al. Apr 2005 A1
20050165275 Von Felten et al. Jul 2005 A1
20050203340 Butler et al. Sep 2005 A1
20050272974 Iddan Dec 2005 A1
20050277966 Ewers et al. Dec 2005 A1
20060041188 Dirusso et al. Feb 2006 A1
20060047183 Park Mar 2006 A1
20060058582 Maahs et al. Mar 2006 A1
20060129130 Tal et al. Jun 2006 A1
20060192465 Kombluh et al. Aug 2006 A1
20060258906 Binmoeller Nov 2006 A1
20060264707 Kinney Nov 2006 A1
20060264821 Vo et al. Nov 2006 A1
20060287666 Saadat et al. Dec 2006 A1
20070015965 Cox et al. Jan 2007 A1
20070038025 Yoshida Feb 2007 A1
20070045504 Wollschlager Mar 2007 A1
20070088367 Von Weymarn-Scharli Apr 2007 A1
20070100414 Licata et al. May 2007 A1
20070106302 Ortiz May 2007 A1
20070118015 Wendlandt May 2007 A1
20070156018 Krauter et al. Jul 2007 A1
20070161851 Takizawa Jul 2007 A1
20070219411 Dejima et al. Sep 2007 A1
20070239252 Hopkins et al. Oct 2007 A1
20070250149 Oepen et al. Oct 2007 A1
20070260121 Bakos et al. Nov 2007 A1
20080051635 Tanaka et al. Feb 2008 A1
20080058722 Oepen et al. Mar 2008 A1
20080091073 Park Apr 2008 A1
20080103440 Ferren et al. May 2008 A1
20080139887 Fitzpatrick Jun 2008 A1
20080172037 Huang et al. Jul 2008 A1
20080188928 Salahieh et al. Aug 2008 A1
20080200762 Stokes et al. Aug 2008 A1
20080214893 Tartaglia et al. Sep 2008 A1
20080234546 Kawano et al. Sep 2008 A1
20080242928 Kawano et al. Oct 2008 A1
20080249362 Jiang et al. Oct 2008 A1
20080262300 Ewers et al. Oct 2008 A1
20080275299 Park Nov 2008 A1
20090023983 Stefanchik Jan 2009 A1
20090048483 Yamamoto Feb 2009 A1
20090062611 Toyama Mar 2009 A1
20090062837 Gasche et al. Mar 2009 A1
20090112063 Bakos et al. Apr 2009 A1
20090131752 Park May 2009 A1
20090157068 Kallel et al. Jun 2009 A1
20090187163 Uihlein Jul 2009 A1
20090240202 Drasler et al. Sep 2009 A1
20090259200 Lampropoulos et al. Oct 2009 A1
20090264704 Shtul Oct 2009 A1
20100010308 Braun et al. Jan 2010 A1
20100010437 Miles et al. Jan 2010 A1
20100016663 Maisch et al. Jan 2010 A1
20100036363 Watanabe et al. Feb 2010 A1
20100069712 Yamaya Mar 2010 A1
20100069716 Chin et al. Mar 2010 A1
20100076451 Zwolinski et al. Mar 2010 A1
20100087711 Edwards Apr 2010 A1
20100137686 Meron et al. Jun 2010 A1
20100145151 Fukunaga et al. Jun 2010 A1
20100160735 Bakos Jun 2010 A1
20100204546 Hassidov et al. Aug 2010 A1
20100268025 Belson Oct 2010 A1
20100331625 Rosemurgy et al. Dec 2010 A1
20100331820 Prisco et al. Dec 2010 A1
20110015729 Jimenez et al. Jan 2011 A1
20110023888 Vazales et al. Feb 2011 A1
20110040282 Uihlein Feb 2011 A1
20110046442 Matsushita Feb 2011 A1
20110049282 Danielsson Mar 2011 A1
20110054253 Jordá Albiñana et al. Mar 2011 A1
20110087070 Tilson et al. Apr 2011 A1
20110237888 Matsushita Sep 2011 A1
20110245611 Yeh et al. Oct 2011 A1
20110282149 Vargas et al. Nov 2011 A1
20110301414 Hotto et al. Dec 2011 A1
20110306950 Cucin Dec 2011 A1
20110319714 Roelle et al. Dec 2011 A1
20120022329 Wagh et al. Jan 2012 A1
20120041291 Ferren et al. Feb 2012 A1
20120095548 Gregorich et al. Apr 2012 A1
20120108902 Frassica et al. May 2012 A1
20120130173 Lutze et al. May 2012 A1
20120143005 Yeh et al. Jun 2012 A1
20120165607 Ashida et al. Jun 2012 A1
20120165792 Ortiz et al. Jun 2012 A1
20120172651 Cutrer Jul 2012 A1
20120209062 Qiao Aug 2012 A1
20120277528 Qiao Nov 2012 A1
20120277729 Melsheimer Nov 2012 A1
20130131641 Jimenez et al. May 2013 A1
20130190565 Gora et al. Jul 2013 A1
20130338440 Sinal et al. Dec 2013 A1
20140005683 Stand et al. Jan 2014 A1
20140073853 Swisher et al. Mar 2014 A1
20140081169 Gerding et al. Mar 2014 A1
20140088459 Roush et al. Mar 2014 A1
20140142393 Piskun et al. May 2014 A1
20140155702 Tilson et al. Jun 2014 A1
20140155783 Starksen et al. Jun 2014 A1
20140188054 Iijima et al. Jul 2014 A1
20140234600 Wang et al. Aug 2014 A1
20140243873 Franklin Aug 2014 A1
20140275860 Rottenberg et al. Sep 2014 A1
20140276601 Edward Sep 2014 A1
20140276642 Cully et al. Sep 2014 A1
20140343358 Hameed et al. Nov 2014 A1
20140371764 Oyola et al. Dec 2014 A1
20150018616 Kumoyama Jan 2015 A1
20150038919 Bramwell et al. Feb 2015 A1
20150073216 Papay Mar 2015 A1
20150073409 Watson et al. Mar 2015 A1
20150094656 Salahieh et al. Apr 2015 A1
20150119640 Reydel Apr 2015 A1
20150126814 Mesallum et al. May 2015 A1
20150133729 Reydel May 2015 A1
20150148602 Hill et al. May 2015 A1
20150148606 Rottenberg et al. May 2015 A1
20150164314 Peterson Jun 2015 A1
20150216589 Wittenberger et al. Aug 2015 A1
20150342608 Hernandez Dec 2015 A1
20150369325 Bureau et al. Dec 2015 A1
20160007832 Shimada Jan 2016 A1
20160066773 Cooper et al. Mar 2016 A1
20160096004 Gerrans et al. Apr 2016 A1
20160129547 Duescher et al. May 2016 A1
20160136393 Tsai et al. May 2016 A1
20160174829 Reydel Jun 2016 A1
20160198935 Choi et al. Jul 2016 A1
20160270870 Kowshik Sep 2016 A1
20160287059 Ha et al. Oct 2016 A1
20160324412 Hassidov et al. Nov 2016 A1
20170156567 Kaneko Jun 2017 A1
20170157363 Barrish et al. Jun 2017 A1
20170340862 Calabrese et al. Nov 2017 A1
20170360281 Ponsky Dec 2017 A1
20180015257 Krolik et al. Jan 2018 A1
20180064366 Sweeney et al. Mar 2018 A1
20180132705 Higuchi May 2018 A1
20180184885 St. George Jul 2018 A1
20180249893 Yeung et al. Sep 2018 A1
20180263469 Okaniwa et al. Sep 2018 A1
20180264239 Piskun Sep 2018 A1
20180271354 Tilson et al. Sep 2018 A1
20180289925 Palmer et al. Oct 2018 A1
20180326197 McArthur et al. Nov 2018 A1
20180361116 Quick et al. Dec 2018 A1
20180374603 Greenwood Dec 2018 A1
20200100653 Nakamura Apr 2020 A1
20200171276 Onozuka Jun 2020 A1
20200178763 Tilson et al. Jun 2020 A1
20200315433 Axon et al. Oct 2020 A1
20200383677 Piligian et al. Dec 2020 A1
20210030260 Julian et al. Feb 2021 A1
20210137366 Tilson et al. May 2021 A1
20230001134 Tilson et al. Jan 2023 A1
20230014281 Tilson et al. Jan 2023 A1
20230338702 Tilson et al. Oct 2023 A1
Foreign Referenced Citations (68)
Number Date Country
2013207571 Aug 2013 AU
2613655 Apr 2004 CN
1706349 Dec 2005 CN
1732855 Feb 2006 CN
1806770 Jul 2006 CN
1861011 Nov 2006 CN
101119765 Feb 2008 CN
101129255 Feb 2008 CN
101888872 Nov 2010 CN
102137628 Jul 2011 CN
201899767 Jul 2011 CN
102711585 Oct 2012 CN
102872519 Jan 2013 CN
103384500 Nov 2013 CN
104168860 Nov 2014 CN
104287684 Mar 2016 CN
105759418 Jul 2016 CN
105832279 Aug 2016 CN
106137397 Nov 2016 CN
106455929 Feb 2017 CN
106488744 Mar 2017 CN
106659367 May 2017 CN
107296584 Oct 2017 CN
102005039601 Feb 2007 DE
401129 Dec 1990 EP
0941743 Sep 1999 EP
1662972 Jun 2006 EP
1695657 Aug 2006 EP
1487318 Mar 2008 EP
2016914 Jan 2009 EP
1499227 Oct 2010 EP
2258322 Dec 2010 EP
2364637 Sep 2011 EP
2368481 Sep 2011 EP
2368483 Sep 2011 EP
3256052 Dec 2017 EP
2604175 Nov 2019 EP
2482355 Oct 2010 GB
2497544 Jun 2013 GB
H05293077 Nov 1993 JP
2002125921 May 2002 JP
2005152300 Jun 2005 JP
2005323778 Nov 2005 JP
03965108 Aug 2007 JP
2009507617 Feb 2009 JP
2009061173 Mar 2009 JP
2011194126 Oct 2011 JP
2013176465 Sep 2013 JP
2014124475 Jul 2014 JP
10-2015-0131502 Nov 2015 KR
20180053852 May 2018 KR
WO9743941 Nov 1997 WO
WO99053827 Oct 1999 WO
WO03013348 Feb 2003 WO
WO2007035931 Mar 2007 WO
WO2008041809 Apr 2008 WO
WO2008122969 Oct 2008 WO
WO2008122997 Oct 2008 WO
WO2009154192 Dec 2009 WO
WO2011018147 Feb 2011 WO
WO2011018157 Feb 2011 WO
WO2011148172 Dec 2011 WO
WO2012054480 Apr 2012 WO
WO2012080947 Jun 2012 WO
WO2012122288 Sep 2012 WO
WO2016034598 Mar 2016 WO
WO2017041052 Mar 2017 WO
WO2018035452 Aug 2017 WO
Non-Patent Literature Citations (22)
Entry
Entrada@ colonic overtube product brochure downloaded from internet http://www.usendoscopy.com/˜/media/Files/Documents/Spec-Sheet-International/760358c_entrada_intl_ss_web.pdf Accessed Date: Jun. 5, 2017 (year of pub sufficiently earlier than effective US filing date and any foreign priority date) 2009.
Filip et al.; Design, Implementation, and Testing of a miniature self-stabilizing capsule endoscope with wireless image transmission capabilities; Int. Joumal “information Technologies & Knowledge”; 5(1); downloaded from http://www.foibg.com/ijilk/ijilk-vol05/ijitk05-1-p01.pdf on Jul. 28, 2016, (year of pub sufficiently earlier than effective US filing date and any foreign priority date) 2011.
Loeve et al.; Endoscope Shaft-Rigidity Control Mechanism: “Forguide”; IEEE Trans. on Biomed. Eng.; 59(2); pp. 542-551; Feb. 2012.
Loeve et al.; Vacuum packed particles as flexible endoscope guides with controllable rigidity; Granular Matter; 12(6); pp. 543-554; Jun. 24, 2010.
Shah et al.; Magnetic Imaging of Colonoscopy: An Audit of Looping, Accuracy and Ancillary maneuvers; Gastrointest. Endosc.; 52(1); pp. 1-8; Jul. 1, 2000.
Simi et al.; Design, Fabrication, and Testing of a Capsule With Hybrid Locomotion for Gastrointestinal Tract Exploration; IEEE/ASME Trans on Mechatronics; 15(2); pp. 170-x; Apr. 2010.
Valdastri et al.; Advanced Technologies for Gastrointestinal Endoscopy; Annu. Rev. Biomed. Eng.; 14; pp. 397-429; May 2012.
Zhao et al.; Development of a variable stiffness over tube based on low-melting-point-alloy for endoscopic surgery; J. Med. Devices; 10(2); 8 pages; May 12, 2016.
Tilson et al.; U.S. Appl. No. 17/493,785 entitled “Dynamically rigidizing composite medical structures,” filed Oct. 4, 2021.
Tilson et al.; U.S. Appl. No. 17/644,758 entitled “Device for endoscopic advancement through the small intestine,” filed Dec. 16, 2021.
Tilson et al.; U.S. Appl. No. 17/604,203 entitled “Dynamically rigidizing composite medical structures,” filed Oct. 15, 2021.
Dow, Dow white paper: Can you estimate modulus from durometer hardness for silicones: Yes, but you only roughly and you must choose your modulus carefully!; 5 pages; retrieved from the internet (https://www.dow.com/content/dam/doc/documents/en-us/tech-art/11/11-37/11-3716-01-durometer-hardness-for-silicones.pdf) on Jan. 18, 2023.
Lopez et al.; U.S. Appl. No. 17/995,294 entitled “Layered walls for rigidizing devices,” filed Sep. 30, 2022.
Scheeff et al.; U.S. Appl. No. 18/000,062 entitled “Rigidizing devices,” filed Nov. 28, 2022.
Gomes et al.; U.S. Appl. No. 18/044,027 entitled “Dynamically rigidizing guiderail and methods of use,” filed Mar. 3, 2023.
Tilson et al.; U.S. Appl. No. 18/325,974 entitled “Endscope sheath apparatuses,” filed May 30, 2023.
Tilson et al.; U.S. Appl. No. 18/325,979 entitled “Apparatuses and methods for determining if an endscope is contaminated,” filed May 30, 2023.
Tilson et al.; U.S. Appl. No. 18/325,990 entitled “Multi-lumen port adapter mainfold devices and methods of use,” filed May 30, 2023.
Gomes et al.; U.S. Appl. No. 18/263,517 entitled “Devices and methods to prevent inadvertent motion of dynamically rigidizing apparatuses,” filed Jul. 28, 2023.
Lopez et al.; U.S. Appl. No. 18/334,555 entitled “Layered walls for rididizing devices,” filed Jun. 14, 2023.
Tilson et al.; U.S. Appl. No. 18/262,904 entitled “Large diameter hemostasis valves,” filed Jul. 25, 2023.
Bearing Works; PTFE Datasheet; 2 pages; Jan. 21, 2021 retrieved from the internet (https://www.bearingworks.com/uploaded-assets/pdfs/retainers/ptfe-datasheet.pdf) on Nov. 10, 2023.
Related Publications (1)
Number Date Country
20220000355 A1 Jan 2022 US
Provisional Applications (1)
Number Date Country
62376816 Aug 2016 US
Continuations (1)
Number Date Country
Parent 16325497 US
Child 17448188 US